Scorpius Holdings, Inc. financial data

Symbol
SCPX on NYSE
Industry
Pharmaceutical Preparations
Location
627 Davis Drive, Suite 300, Morrisville, NC
State of incorporation
DE
Fiscal year end
December 31
Former names
NightHawk Biosciences, Inc. (to 1/30/2024), HEAT BIOLOGICS, INC. (to 4/25/2022)
Latest financial report
10-Q - Q3 2024 - Nov 14, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 44.1 % -74.7%
Quick Ratio 5.9 %
Debt-to-equity 82.9 % +38%
Return On Equity -115 % -11.7%
Return On Assets -59.2 % +6.98%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 3.12M shares
Common Stock, Shares, Outstanding 3.54M shares -86.4%
Entity Public Float 16.6M USD -74.7%
Common Stock, Value, Issued 2.97K USD -43%
Weighted Average Number of Shares Outstanding, Basic 7.06M shares +5317%
Weighted Average Number of Shares Outstanding, Diluted 7.06M shares +5317%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 15.3M USD -32.8%
General and Administrative Expense 25.7M USD +43.7%
Costs and Expenses 40.2M USD -20.1%
Operating Income (Loss) -30.1M USD +37.4%
Nonoperating Income (Expense) -874K USD -230%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -31M USD +35.9%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -28.8M USD +47.6%
Earnings Per Share, Basic 178 USD/shares +98.6%
Earnings Per Share, Diluted 178 USD/shares +98.6%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 4.56M USD +123%
Cash, Cash Equivalents, and Short-term Investments 4.8M USD -22.6%
Accounts Receivable, after Allowance for Credit Loss, Current 203K USD -35.3%
Inventory, Net 175K USD
Assets, Current 6.38M USD -73.6%
Property, Plant and Equipment, Net 14.1M USD -24.7%
Operating Lease, Right-of-Use Asset 5.28M USD -1.27%
Goodwill 3.87M USD -23.6%
Other Assets, Noncurrent 24.6M USD +156%
Assets 46.5M USD -33.4%
Accounts Payable, Current 2.41M USD -16%
Employee-related Liabilities, Current 595K USD +59.5%
Accrued Liabilities, Current 2.34M USD +15.1%
Contract with Customer, Liability, Current 2.11M USD -47.9%
Liabilities, Current 10.3M USD -57.8%
Contract with Customer, Liability, Noncurrent 227K USD +597%
Deferred Income Tax Liabilities, Net 3.33M USD +819%
Operating Lease, Liability, Noncurrent 3.17M USD +12.1%
Other Liabilities, Noncurrent 56.5K USD +15.3%
Liabilities 22M USD -39.7%
Accumulated Other Comprehensive Income (Loss), Net of Tax 16.3K USD -89.8%
Retained Earnings (Accumulated Deficit) -278M USD -11.6%
Stockholders' Equity Attributable to Parent 28.7M USD -20.8%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 24.5M USD -26.6%
Liabilities and Equity 46.5M USD -33.4%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -4.68M USD +66%
Net Cash Provided by (Used in) Financing Activities 3.27M USD
Net Cash Provided by (Used in) Investing Activities 2.78M USD -79.4%
Common Stock, Shares Authorized 250M shares 0%
Common Stock, Shares, Issued 3.54M shares -86.4%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 1.37M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 4.56M USD -15%
Deferred Tax Assets, Valuation Allowance 40.5M USD +24.3%
Operating Lease, Liability 3.63M USD +12.4%
Depreciation 4.9M USD +11.4%
Payments to Acquire Property, Plant, and Equipment 299K USD -81.6%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -29M USD +47.4%
Lessee, Operating Lease, Liability, to be Paid 4.75M USD +7.51%
Property, Plant and Equipment, Gross 25M USD -0.14%
Operating Lease, Liability, Current 462K USD +14.2%
Lessee, Operating Lease, Liability, to be Paid, Year Two 828K USD +30.4%
Lessee, Operating Lease, Liability, to be Paid, Year One 802K USD +20%
Operating Lease, Weighted Average Discount Rate, Percent 0.1 pure 0%
Deferred Income Tax Expense (Benefit) 600K USD -40%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 1.13M USD -5.63%
Lessee, Operating Lease, Liability, to be Paid, Year Three 856K USD +48.7%
Deferred Tax Assets, Operating Loss Carryforwards 28.9M USD +17.8%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 0 USD -100%
Lessee, Operating Lease, Liability, to be Paid, Year Four 884K USD +49.2%
Operating Lease, Payments 800K USD 0%
Additional Paid in Capital 306M USD +7.51%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 364K USD +3.93%
Depreciation, Depletion and Amortization 1.81M USD +26.7%
Deferred Tax Assets, Net of Valuation Allowance 46.8M USD +30.1%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%